Chemoinformaics analysis of N-(3,4-dimethoxybenzyl)-N-isopentylamine
| Molecular Weight | 237.343 | nRot | 7 |
| Heavy Atom Molecular Weight | 214.159 | nRig | 6 |
| Exact Molecular Weight | 237.173 | nRing | 1 |
| Solubility: LogS | -2.441 | nHRing | 0 |
| Solubility: LogP | 2.719 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 41.4202 |
| nHD | 1 | BPOL | 27.1158 |
| QED | 0.74 |
| Synth | 1.69 |
| Natural Product Likeliness | -0.334 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.014 |
| Pgp-sub | 0.994 |
| HIA | 0.004 |
| CACO-2 | -4.39 |
| MDCK | 0.0000487 |
| BBB | 0.797 |
| PPB | 0.342332 |
| VDSS | 3.399 |
| FU | 0.274716 |
| CYP1A2-inh | 0.741 |
| CYP1A2-sub | 0.89 |
| CYP2c19-inh | 0.45 |
| CYP2c19-sub | 0.937 |
| CYP2c9-inh | 0.031 |
| CYP2c9-sub | 0.667 |
| CYP2d6-inh | 0.959 |
| CYP2d6-sub | 0.917 |
| CYP3a4-inh | 0.558 |
| CYP3a4-sub | 0.479 |
| CL | 9.161 |
| T12 | 0.747 |
| hERG | 0.336 |
| Ames | 0.007 |
| ROA | 0.83 |
| SkinSen | 0.607 |
| Carcinogencity | 0.046 |
| EI | 0.066 |
| Respiratory | 0.908 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.81681 |